Quorum Health Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported net operating revenues of $529,737,000 against $538,352,000 a year ago. Loss from operations was $259,255,000 against income from operations of $27,484,000 a year ago. Loss before income taxes was $288,531,000 against income from operations of $3,656,000 a year ago. Net loss attributable to the company was $245,061,000 against income of $1,430,000 a year ago. Basic and diluted loss per share attributable to the company was $8.63 against basic and diluted earnings per share was $0.05 a year ago. Net cash provided by operating activities was $36,796,000 against $56,346,000 a year ago. Capital expenditures for property and equipment were $20,367,000 against $10,471,000 a year ago. Capital expenditures for software were $1,278,000 against $1,664,000 a year ago. LBITDA was $227,792,000 against EBITDA of $59,625,000 a year ago. Adjusted EBITDA was $29,232,000 against $59,625,000 a year ago.

For the six months, the company reported net operating revenues of $1,079,288,000 against $1,085,969,000 a year ago. Loss from operations was $238,164,000 against income from operations of $61,815,000 a year ago. Loss before income taxes was $294,892,000 against income from operations of $12,185,000 a year ago. Net loss attributable to the company was $250,063,000 against income of $7,629,000 a year ago. Basic and diluted loss per share attributable to the company was $8.80 against basic and diluted earnings per share was $0.27 a year ago. Net cash provided by operating activities was $61,193,000 against $22,696,000 a year ago. Capital expenditures for property and equipment were $33,207,000 against $20,410,000 a year ago. Capital expenditures for software were $3,804,000 against $2,661,000 a year ago. LBITDA was $175,544,000 against EBITDA of $125,654,000 a year ago. Adjusted EBITDA was $85,456,000 against $125,654,000 a year ago.

For the quarter, the company reported impairment of long-lived assets and goodwill of $250,400,000.

The company expects net operating revenues for the year ending December 31, 2016 to range from $2.15 billion to $2.20 billion and expects adjusted EBITDA to range from $175 million to $200 million.